Hillsborough, NJ, United States of America

Hong Liu

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 7.2

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • River Edge, NJ (US) (2006 - 2008)
  • Hackensack, NJ (US) (2005 - 2010)
  • Kenilworth, NJ (US) (2013 - 2020)
  • Hillsborough, NJ (US) (2012 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
28 patents (USPTO):

Title: The Innovative Work of Hong Liu in Advancing Pain Management Therapies

Introduction

Hong Liu, based in Hillsborough, NJ, is an accomplished inventor with a significant portfolio of 27 patents. His innovative contributions primarily focus on the development of novel pharmaceutical compounds aimed at treating various pain-related disorders.

Latest Patents

Among his latest inventions are two notable patents: the first relates to "2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors." These compounds are designed to inhibit Na1.8 channel activity and hold potential for treating and managing pain disorders, cough disorders, as well as acute and chronic itch disorders. The second patent concerns "2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors," which serves a similar therapeutic purpose. Both patent families are groundbreaking in their approach to channel activity modulation, providing promising avenues for medical advancements.

Career Highlights

Hong Liu has significantly impacted the pharmaceutical field through his work with renowned companies such as Merck Sharp & Dohme Corporation and Schering Corporation. His tenure at these leading institutions allowed him to refine his research and development skills, contributing to numerous innovative medicines that address critical health issues.

Collaborations

Throughout his career, Hong has collaborated with talented professionals including Xing Dai and Bernard R. Neustadt. These partnerships have enabled the synthesis of innovative ideas and research methodologies, further enhancing the quality and applicability of his inventions.

Conclusion

Hong Liu stands out as a notable inventor whose work has the potential to significantly influence the treatment landscape for pain and itch disorders. With a track record of successful patents and collaborations, he continues to push the boundaries of pharmaceutical research, making considerable contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…